SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-15-000129
Filing Date
2015-03-25
Accepted
2015-03-24 19:00:44
Documents
5
Period of Report
2015-03-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K rgbp20150324form8k.htm 8-K 51200
2 CONVERTIBLE PROMISSORY NOTE rgbp20150324form8kex10_1.htm EX-10.1 23511
3 CONVERTIBLE PROMISSORY NOTE rgbp20150324form8kex10_2.htm EX-10.2 23536
4 SUBLEASE AGREEMENT rgbp20150324form8kex10_3.htm EX-10.3 42899
5 RESEARCH AGREEMENT rgbp20150324form8kex10_4.htm EX-10.4 31378
  Complete submission text file 0001607062-15-000129.txt   173664
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-191725 | Film No.: 15722944
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1